- Supported exchanges /
- SHE /
- 000518.SHE
Jiangsu Sihuan Bioengineering Co Ltd (000518 SHE) stock market data APIs
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusen, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass; Xinde Lusheng; Xin Lisheng; and Ring BO. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.
Jiangsu Sihuan Bioengineering Co Ltd Financial Data Overview
3.09 | |
2.75 | |
- | |
3.09 | |
2.72 | |
1.72-4.57 | |
2 986 M | |
1 030 M | |
211 M | |
-0.0035 | |
0.575 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Jiangsu Sihuan Bioengineering Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 211 M
- EBITDA -26 531 548
- Earnings Per Share -0.05
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Jiangsu Sihuan Bioengineering Co Ltd Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Jiangsu Sihuan Bioengineering Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: